Bivalirudin during primary PCI in acute myocardial infarction Academic Article uri icon

Overview

MeSH Major

  • Angioplasty, Balloon, Coronary
  • Antithrombins
  • Myocardial Infarction
  • Peptide Fragments
  • Stents

abstract

  • In patients with ST-segment elevation myocardial infarction who are undergoing primary PCI, anticoagulation with bivalirudin alone, as compared with heparin plus glycoprotein IIb/IIIa inhibitors, results in significantly reduced 30-day rates of major bleeding and net adverse clinical events. (ClinicalTrials.gov number, NCT00433966 [ClinicalTrials.gov].).

publication date

  • May 22, 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1056/NEJMoa0708191

PubMed ID

  • 18499566

Additional Document Info

start page

  • 2218

end page

  • 30

volume

  • 358

number

  • 21